• Investment World
• eWorld
• Brand Line
• Mentor
• Life
• Brand Quest
• The New Manager

Stocks

• Quotes
• SE Diary
• Scoreboard
• Open-End Mutual Fund

Cross Currency

• Rates
  
  

Shipping

• Ports
  
  

Archives

• Yesterday
• Datewise
• Resources
• In Focus
• In Depth
• Events 2007

Group Sites

• The Hindu
• The Hindu ePaper
• Business Line
• Business Line ePaper
• Sportstar
• Frontline
• The Hindu eBooks
• The Hindu Images

Bangalore, April 4

The Bangalore-based pharma company Micro Labs has joined the Rs 1,000-crore-turnover club, a company release here said. It plans to invest Rs 100 crore in a new facility here and also open a new R&D centre in Mumbai in July with an investment of Rs 60 crore. Exports grew 20 per cent to Rs 325 crore during 2007-08. The company makes cardio-vascular drugs, antibiotics, anti-diabetics, skin and eye-care products, neuro-psychiatry, gastro-intestinals, pain killers through 14 specialty divisions. Of these, Micro Main and Carsyon have crossed the Rs 100-crore mark. According to the latest secondary sales data released by ORG-IMS, Micro Labs has regained its position in the top 20 companies with 25 per cent growth for January and February 2008. —

Our Bureau

More Stories on : Research & Development | Pharmaceuticals

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

Stories in this Section
Micro Labs in Rs 1,000-cr league

Copyright © 2008, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line